298 related articles for article (PubMed ID: 19417026)
1. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Small GW; Shi YY; Higgins LS; Orlowski RZ
Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
6. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
[TBL] [Abstract][Full Text] [Related]
7. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
Toh ML; Yang Y; Leech M; Santos L; Morand EF
Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
11. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
Loda M; Capodieci P; Mishra R; Yao H; Corless C; Grigioni W; Wang Y; Magi-Galluzzi C; Stork PJ
Am J Pathol; 1996 Nov; 149(5):1553-64. PubMed ID: 8909245
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance.
Wang Z; Xu J; Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 Sep; 66(17):8870-7. PubMed ID: 16951204
[TBL] [Abstract][Full Text] [Related]
13. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma.
Davidson B; Konstantinovsky S; Kleinberg L; Nguyen MT; Bassarova A; Kvalheim G; Nesland JM; Reich R
Gynecol Oncol; 2006 Sep; 102(3):453-61. PubMed ID: 16494928
[TBL] [Abstract][Full Text] [Related]
14. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
Givant-Horwitz V; Davidson B; Reich R
Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
[TBL] [Abstract][Full Text] [Related]
15. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
[TBL] [Abstract][Full Text] [Related]
16. c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.
Shimada K; Nakamura M; Ishida E; Higuchi T; Tanaka M; Ota I; Konishi N
Am J Pathol; 2007 Sep; 171(3):1003-12. PubMed ID: 17690186
[TBL] [Abstract][Full Text] [Related]
17. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
[TBL] [Abstract][Full Text] [Related]
18. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.
Schmitz KJ; Grabellus F; Callies R; Otterbach F; Wohlschlaeger J; Levkau B; Kimmig R; Schmid KW; Baba HA
Breast Cancer Res; 2005; 7(2):R194-203. PubMed ID: 15743500
[TBL] [Abstract][Full Text] [Related]
19. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx.
Garavello W; Nicolini G; Aguzzi A; Maggioni D; Leone BE; Viganò P; Gaini RM; Tredici G
Oncol Rep; 2006 Sep; 16(3):479-84. PubMed ID: 16865246
[TBL] [Abstract][Full Text] [Related]
20. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
